Immunic Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +7.1% | +6.7% | +150.0% | -47.5% | -4.8% | -15.0% | +11.8% | +68.4% | -31.3% | +54.5% | -32.4% | +13.0% | +19.2% | +35.5% | -16.7% | +22.9% | +0.0% | – | – | -21.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.7% | +8.6% | +2.1% | -1.5% | +5.2% | -0.3% | -14.7% | -30.8% | -99.7% | +2,370.0% | +1,120.4% | +17.8% | -15.2% | +6.8% | +55.2% | +10.5% | +1.2% | +3.1% | +36.6% | -1.6% | +18.7% | -5.1% | -5.2% | 0.0% | +25.4% | +10.7% | -7.8% | -6.5% | -2.6% | -2.8% | -2.2% | +16.6% | +1.2% | -0.4% | -0.8% | -6.4% | -4.7% | +34.4% | +1.2% | – | |
| – | +7.0% | +3.2% | -11.2% | +8.7% | +55.6% | -5.6% | -1.8% | -42.2% | +2.8% | +6.3% | +233.8% | -76.9% | +4.1% | +19.4% | -13.4% | +12.1% | +20.3% | +20.0% | -5.1% | -15.3% | +15.0% | +19.4% | +2.1% | -12.1% | +1.2% | +18.4% | -10.2% | -1.9% | +8.6% | +25.6% | -12.7% | -3.0% | -7.9% | +31.8% | +8.0% | +4.7% | -28.8% | +77.9% | +24.0% | – | |
| – | +15.5% | +7.3% | -1.1% | +0.7% | +16.9% | -1.9% | -10.9% | -16.0% | -98.6% | +1,941.0% | +371.3% | -38.8% | -10.8% | +10.1% | +35.6% | +10.8% | +4.8% | +128.2% | -40.8% | -4.1% | +18.1% | -1.3% | -3.8% | -2.4% | +185.0% | -52.5% | -8.2% | -5.8% | -0.9% | +2.1% | -4.5% | +12.9% | -0.5% | +4.8% | +1.0% | -4.0% | -10.3% | +42.3% | +6.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +32.8% | -88.4% | – | – | – | – | +70.6% | +84.5% | -77.6% | -83.3% | +400.0% | -50.0% | +180.0% | -53.6% | -23.1% | +50.0% | -53.3% | +1,414.3% | +117.0% | +203.5% | +188.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +109.9% | +172.0% | -97.6% | -137.7% | – | – | – | – | – | -300.0% | – | – | – | – | – | – | +2,798.6% | -106.3% | – | – | – | -100.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.